Blue Water Biotech
A Nasdaq commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for oncology.
Launch date
Employees
Market cap
$4.8m
Enterprise valuation
$10m (Public information from Dec 2023)
Share price
$0.166 BWV
Cincinnati Ohio (HQ)
Financials
Estimates*
USD | 2019 | 2020 | 2021 | 2022 | 2024 |
---|---|---|---|---|---|
Revenues | - | - | - | - | <1m |
EBITDA | (<1m) | (1.6m) | (3.4m) | (13.5m) | - |
Profit | (<1m) | (1.6m) | (3.4m) | (13.4m) | - |
R&D budget | <1m | <1m | 1.3m | 4.1m | - |
Related Content
Recent News about Blue Water Biotech
EditInvestments by Blue Water Biotech
EditACQUISITION by Onconetix Dec 2023